- Home
- PEBO vs XOMAO Comparison
PEBO vs XOMAO Comparison
Compare PEBO & XOMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEBO
- XOMAO
- Stock Information
- Founded
- PEBO 1902
- XOMAO N/A
- Country
- PEBO United States
- XOMAO United States
- Employees
- PEBO N/A
- XOMAO 13
- Industry
- PEBO Major Banks
- XOMAO Biotechnology: Pharmaceutical Preparations
- Sector
- PEBO Finance
- XOMAO Health Care
- Exchange
- PEBO Nasdaq
- XOMAO Nasdaq
- Market Cap
- PEBO N/A
- XOMAO N/A
- IPO Year
- PEBO N/A
- XOMAO N/A
- Fundamental
- Price
- PEBO $35.44
- XOMAO $25.53
- Analyst Decision
- PEBO Hold
- XOMAO
- Analyst Count
- PEBO 3
- XOMAO 0
- Target Price
- PEBO $34.33
- XOMAO N/A
- AVG Volume (30 Days)
- PEBO 151.1K
- XOMAO N/A
- Earning Date
- PEBO 10-22-2024
- XOMAO N/A
- Dividend Yield
- PEBO 4.51%
- XOMAO N/A
- EPS Growth
- PEBO 3.01
- XOMAO N/A
- EPS
- PEBO 3.51
- XOMAO N/A
- Revenue
- PEBO $428,740,000.00
- XOMAO N/A
- Revenue This Year
- PEBO N/A
- XOMAO N/A
- Revenue Next Year
- PEBO $1.10
- XOMAO N/A
- P/E Ratio
- PEBO $10.10
- XOMAO N/A
- Revenue Growth
- PEBO 10.64
- XOMAO N/A
- 52 Week Low
- PEBO $26.74
- XOMAO N/A
- 52 Week High
- PEBO $36.19
- XOMAO N/A
- Technical
- Relative Strength Index (RSI)
- PEBO 66.22
- XOMAO 49.89
- Support Level
- PEBO $33.88
- XOMAO $25.47
- Resistance Level
- PEBO $36.19
- XOMAO $25.66
- Average True Range (ATR)
- PEBO 0.95
- XOMAO 0.10
- MACD
- PEBO 0.41
- XOMAO -0.01
- Stochastic Oscillator
- PEBO 88.24
- XOMAO 69.67
About XOMAO AGNC Investment Corp.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.